000			01864 a2200493 4500
005			20250516124237.0
264		0	_c20140114
008			201401s 0 0 eng d
022			_a1976-2437
024	7		_a10.3349/ymj.2013.54.1.253 _2doi
040			_aNLM _beng _cNLM
100	1		_aPieringer, Herwig
245	0	0	_aPatients with arthritis undergoing surgery: how should we manage tumour necrosis factor blocking agents perioperatively?-A systematic literature review. _h[electronic resource]
260			_bYonsei medical journal _cJan 2013
300			_a253-7 p. _bdigital
500			_aPublication Type: Journal Article; Review; Systematic Review
650	0	4	_aAdalimumab
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis _xsurgery
650	0	4	_aCertolizumab Pegol
650	0	4	_aEtanercept
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xtherapeutic use
650	0	4	_aImmunoglobulin G _xtherapeutic use
650	0	4	_aInfections
650	0	4	_aInfliximab
650	0	4	_aPerioperative Period
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aPostoperative Complications _xprevention & control
650	0	4	_aPostoperative Period
650	0	4	_aReceptors, Tumor Necrosis Factor _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aRisk
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aDanninger, Kathrin
700	1		_aTzaribachev, Nikolay
700	1		_aBöhler, Nikolaus
700	1		_aPohanka, Erich
700	1		_aHerold, Manfred
773	0		_tYonsei medical journal _gvol. 54 _gno. 1 _gp. 253-7
856	4	0	_uhttps://doi.org/10.3349/ymj.2013.54.1.253 _zAvailable from publisher's website
999			_c22332980 _d22332980